Artificial intelligence is reshaping healthcare, but many organizations are still struggling to unlock its full potential. Success starts with people, processes, and strategy – not just technology.

At HIMSS25 in Las Vegas, the AI in Healthcare Forum, which is slated to run all day Monday, March 3, will host experts from across the healthcare industry to discuss technology and tactics, exploring how to build responsible AI strategies, align them with business goals, and establish strong data governance.

The aim is to give attendees valuable and actionable insights for selecting the right technology, ensuring seamless integration, and driving measurable impact across diagnostics, treatment, and patient care.

An ideal place to start would be with keynote speaker Dennis Chornenky, chief AI advisor for UC Davis Health, who will kick off the sessions with an examination of the challenges of AI in healthcare, focusing on policy, strategy, and responsible implementation.

The former AI policy leader at the White House will discuss how organizations can navigate policy gaps, develop ethical AI strategies, and prepare teams for emerging technologies.

The session will also explore innovative ways to address disparities and ensure AI benefits all stakeholders and offer attendees a path to leveraging AI effectively while staying ahead of regulatory and technological shifts.

Later in the day, participants can get a handle on the scope of the changes impacting healthcare and cutting through the tech propaganda would be with Microsoft’s chief medical officer, federal civilian, Dr. Thomas Osborne, who will go beyond the hype and outline the state-of-the-art technologies transforming healthcare – with AI at the top of the list.

By offering his take on what the impact will be on personalized and efficient care – along with challenges to widespread adoption – Osborne will offer participants a slew of critical insights to help them integrate, avoid disruption and reap the benefits for their organizations.

A moderated panel featuring Rhett Alden, chief technology officer, health market, Elsevier and the company’s physician clinical executive Paul Helmuth, along with Jennifer A.H. Bell, senior bioethicist and clinician scientist, University Health Network, will focus on the critical aspects of responsible AI in healthcare.

The discussion, led by Brian Spisak, senior partner and program director of AI and leadership, C-suite growth advisors & Harvard University, will cover AI bias, collaboration strategies, and ethical frameworks to ensure transparency, accountability, and fairness in AI-driven healthcare solutions.

Brian Paradis founder and CEO of Csuite Growth Advisors will address the fundamental importance of securing CFO buy-in for AI investment through discussions about return on investment. Among the key topics will be strategies to align AI with financial goals, optimizing operations, and demonstrating ROI for mission-critical innovation.

Another panel, moderated by Attila Hertelendy, assistant professor at Florida International University, will focus on the human factors critical to AI development in healthcare.

Panelists Spencer Dorn, vice chair and Professor of Medicine at UNC Chapel Hill, Mark Sendak, population health and data science lead at Duke Institute for Health Innovation, Scott Hadaway, Field CTO at ServiceNow and Irene Louh, VP of data intelligence and decision science at Baptist Health, will discuss how AI integration goes beyond technical readiness, requiring strong change management across clinical, quality, regulatory, and administrative teams.

The discussion will explore strategies for transparent communication, targeted training, and continuous feedback to ease workforce adoption. Panelists will address challenges such as clinician burnout, staff turnover, and the need to improve job satisfaction by reinvesting AI-driven time savings into employee well-being.